On October 16, 2023 Median Technologies (ALMDT:PA) reported that the Company will be participating in the prestigious 2023 European Society for Medical Oncology (ESMO) (Free ESMO Whitepaper) Congress, set to take place in Madrid, Spain (venue: IFEMA) (Press release, MEDIAN Technologies, OCT 16, 2023, View Source [SID1234636045]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event, scheduled from October 20th to 24th, promises to be a remarkable platform for the exchange of groundbreaking insights and cutting-edge developments in the field of oncology.

"As a testament to the commitment of advancing cancer care worldwide, we will be participating with the goal of sharing our expertise in clinical trial imaging as well as advanced, AI-powered insights," said Nicolas Dano, Chief Operating Officer, iCRO, of Median Technologies. "We are thrilled to be bringing together for the first time our expert teams spanning across the Europe, United States, and China, and invite all attendees to visit booth #552 to engage with our experts and experience firsthand the impact of our pioneering solutions."

More about the ESMO (Free ESMO Whitepaper) congress: View Source